These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 7648164

  • 1. Effect of aberrant hepatic arterial anatomy on tumour response to hepatic artery infusion of floxuridine for colorectal liver metastases.
    Burke D, Earlam S, Fordy C, Allen-Mersh TG.
    Br J Surg; 1995 Aug; 82(8):1098-100. PubMed ID: 7648164
    [Abstract] [Full Text] [Related]

  • 2. Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. New dose schedules and survival update.
    Kemeny N, Seiter K, Conti JA, Cohen A, Bertino JR, Sigurdson ER, Botet J, Chapman D, Mazumdar M, Budd AJ.
    Cancer; 1994 Feb 15; 73(4):1134-42. PubMed ID: 8313315
    [Abstract] [Full Text] [Related]

  • 3. Extrahepatic biliary stenoses after hepatic arterial infusion (HAI) of floxuridine (FUdR) for liver metastases from colorectal cancer.
    Aldrighetti L, Arru M, Ronzoni M, Salvioni M, Villa E, Ferla G.
    Hepatogastroenterology; 2001 Feb 15; 48(41):1302-7. PubMed ID: 11677951
    [Abstract] [Full Text] [Related]

  • 4. Multidetector CT arteriography with volumetric three-dimensional rendering to evaluate patients with metastatic colorectal disease for placement of a floxuridine infusion pump.
    Kapoor V, Brancatelli G, Federle MP, Katyal S, Marsh JW, Geller DA.
    AJR Am J Roentgenol; 2003 Aug 15; 181(2):455-63. PubMed ID: 12876026
    [Abstract] [Full Text] [Related]

  • 5. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial.
    Hohn DC, Stagg RJ, Friedman MA, Hannigan JF, Rayner A, Ignoffo RJ, Acord P, Lewis BJ.
    J Clin Oncol; 1989 Nov 15; 7(11):1646-54. PubMed ID: 2530317
    [Abstract] [Full Text] [Related]

  • 6. Fluorodeoxyuridine uptake by human colorectal hepatic metastases after hepatic artery infusion.
    Sigurdson ER, Ridge JA, Daly JM.
    Surgery; 1986 Aug 15; 100(2):285-91. PubMed ID: 2943036
    [Abstract] [Full Text] [Related]

  • 7. Percutaneous hepatic arterial infusion (HAI) of mitomycin C and floxuridine (FUDR): an effective treatment for metastatic colorectal carcinoma in the liver.
    Patt YZ, Mavligit GM, Chuang VP, Wallace S, Johnston S, Benjamin RS, Valdivieso M, Hersh EM.
    Cancer; 1980 Jul 15; 46(2):261-5. PubMed ID: 6446376
    [Abstract] [Full Text] [Related]

  • 8. Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C.
    Link KH, Kornmann M, Leder G, Pillasch AF, Sunelaitis E, Schatz M, Pressmar J, Beger HG.
    Gan To Kagaku Ryoho; 1999 Feb 15; 26(3):269-81. PubMed ID: 10065089
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Review of regional therapy of liver metastases in colorectal cancer.
    Kemeny N.
    Semin Oncol; 1992 Apr 15; 19(2 Suppl 3):155-62. PubMed ID: 1532670
    [Abstract] [Full Text] [Related]

  • 12. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer.
    Meta-Analysis Group in Cancer, Piedbois P, Buyse M, Kemeny N, Rougier P, Carlson R, Allen-Mersh T, O'Connell M, Chang A, Sondak V, Kemeny M, Levy E.
    J Natl Cancer Inst; 1996 Mar 06; 88(5):252-8. PubMed ID: 8614003
    [Abstract] [Full Text] [Related]

  • 13. Phase II evaluation of treatment of complete resection of hepatic metastases from colorectal cancer and adjuvant hepatic arterial infusion of floxuridine: an Eastern Cooperative Oncology Group Study (PB083).
    Berlin J, Merrick HW, Smith TJ, Lerner H.
    Am J Clin Oncol; 1999 Jun 06; 22(3):291-3. PubMed ID: 10362339
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial.
    Rougier P, Laplanche A, Huguier M, Hay JM, Ollivier JM, Escat J, Salmon R, Julien M, Roullet Audy JC, Gallot D.
    J Clin Oncol; 1992 Jul 06; 10(7):1112-8. PubMed ID: 1296590
    [Abstract] [Full Text] [Related]

  • 16. A pilot study of hepatic artery floxuridine combined with systemic 5-fluorouracil and leucovorin. A potential adjuvant program after resection of colorectal hepatic metastases.
    Kemeny N, Conti JA, Sigurdson E, Cohen A, Seiter K, Lincer R, Niedzwiecki D, Botet J, Chapman D, Costa P.
    Cancer; 1993 Mar 15; 71(6):1964-71. PubMed ID: 8443746
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Intrahepatic arterial infusion of chemotherapy: pharmacologic principles.
    Ensminger WD.
    Semin Oncol; 2002 Apr 15; 29(2):119-25. PubMed ID: 11951209
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Arterial chemotherapy as adjuvant and palliative treatment of hepatic colorectal metastases: an update.
    Bilchik AJ.
    Surg Oncol Clin N Am; 2003 Jan 15; 12(1):193-210. PubMed ID: 12735138
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.